SPOTLIGHT -
Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer
Robert Dreicer, MD, describes the future of metastatic castration-resistant prostate cancer.
Sabizabulin for Metastatic Castration-Resistant Prostate Cancer
A prostate cancer expert explains the potential advantages of sabizabulin, a new treatment for metastatic castration-resistant prostate cancer currently in a phase III clinical trial.
Second-Line Therapy Options in Metastatic Castration-Resistant Prostate Cancer
Robert Dreicer, MD, discusses the available second-line therapy options and unmet needs in metastatic castration-resistant prostate cancer.
First-Line Therapy Options in Metastatic Castration-Resistant Prostate Cancer
Robert Dreicer, MD, provides an overview of the first-line therapy options available in metastatic castration-resistant prostate cancer and the recent advances in detection, diagnosis, and treatment.